Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2002
12/27/2002WO2001094587A3 Extracellular messengers
12/27/2002WO2001085986A3 Phosphatidyl inositol 3-kinase delta binding partner
12/27/2002WO2001085937A3 Regulator of g protein signalling (rgs8)
12/27/2002WO2001080865A9 Joint repair using mesenchymal stem cells
12/27/2002WO2001074903A9 Cd20/ige-receptor like molecules and uses thereof
12/27/2002CA2782868A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/27/2002CA2782865A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/27/2002CA2782862A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/27/2002CA2782857A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/27/2002CA2782791A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/27/2002CA2782761A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/27/2002CA2782628A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/27/2002CA2782623A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/27/2002CA2782615A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/27/2002CA2782521A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
12/27/2002CA2782519A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
12/27/2002CA2782517A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
12/27/2002CA2782515A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/27/2002CA2782494A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/27/2002CA2455387A1 Fce fusion proteins for treatment of allergy and asthma
12/27/2002CA2451874A1 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells
12/27/2002CA2450936A1 Purine inhibitors of phosphodiesterase (pde) 7
12/27/2002CA2450934A1 Pyrimidine inhibitors of phosphodiesterase (pde) 7
12/27/2002CA2450856A1 Novel aliphatic compounds, their synthesis method, and utilization method of the same
12/27/2002CA2450809A1 Methods for detecting and treating the early onset of aging-related conditions
12/27/2002CA2450724A1 Quinazoline and pyrido¬2,3-d|pyrimidine inhibitors of phosphodiesterase (pde) 7
12/27/2002CA2450067A1 Proteins associated with cell growth, differentiation, and death
12/27/2002CA2449943A1 Preventives or remedies for arthritis
12/27/2002CA2448298A1 Phenylpyridine carbonyl piperazine derivative
12/27/2002CA2444356A1 Orally deliverable pharmaceutical composition comprising an active compound having an aminosulfonyl group (cox-2 inhibitor), a polyethylene glycol and a free-radical scavenging antioxidant
12/27/2002CA2443466A1 An aqueous pharmaceutical preparation of cilostazol for parenteral use
12/26/2002US20020198363 Generation of antithrombic protein; obtain nucleotide sequences coding antithrombic protein, transform microorganism, express nucleotide sequences, recover protein
12/26/2002US20020198261 Liquid pharmaceutical compositions
12/26/2002US20020198260 Polyoxyethylene glycol lipid compounds with long chain fatty acid pendant groups
12/26/2002US20020198253 Melatonin derivatives and medicine containing same
12/26/2002US20020198251 Substituted 2-dialkylaminoalkylbiphenyl derivatives
12/26/2002US20020198248 Therapeutic methods and compositions involving isoflavones
12/26/2002US20020198245 Heterocyclic aromatic oxazole compounds and use thereof
12/26/2002US20020198244 Heterocyclic aromatic oxazole compounds and use thereof
12/26/2002US20020198242 Administering to an animal an effective dose of atleast an enzyme Dipeptidyl Peptidase (DP IV) enzyme activity effector to increase the capacity of insulin producing cells
12/26/2002US20020198214 Such as (3-(4-(4-fluoro-benzyl)-piperidine-1-carbonyl)-4-methoxy-phenyl)-oxo-acetic acid methyl ester for proinflammation response in multiple sclerosis, inflammatory bowel disease, osteoarthritis, and other arthritic conditions
12/26/2002US20020198208 Medicinal preparation and process for manufacturing thereof
12/26/2002US20020198206 Such as 1-Cyclohexyl-4-(4-fluorophenyl)-5-((2-phenylamino)pyrimidin-4-yl)imidazole; for use as cytokine inhibitors
12/26/2002US20020198198 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
12/26/2002US20020198195 New oxybenzamide derivatives useful for inhibiting factor Xa or VIIa
12/26/2002US20020198177 Coenzyme Q and EPA
12/26/2002US20020198170 Formulations of adenosine a1 agonists
12/26/2002US20020198143 B7-like polynucleotides, polypeptides, and antibodies
12/26/2002US20020197654 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof
12/26/2002US20020197312 Dispersible and soluble galenic paracetamol formulation, method for its preparation and its applications
12/26/2002US20020197303 Microbiocide, antipyretics using flower extract
12/26/2002US20020197256 Combination therapy
12/26/2002US20020197233 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists
12/26/2002US20020197210 Stabilized therapeutic and imaging agents
12/25/2002CN1387571A Mammalian cytokines, related reagents and methods
12/25/2002CN1387538A Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders
12/25/2002CN1387530A Imidazopyridine derivs. used as phosphodiesterase VII inhibitors
12/25/2002CN1387528A Heterocyclic substd, pyrazolones
12/25/2002CN1387527A Qinazoline derivs. as VEGF inhibitors
12/25/2002CN1387526A Cyclopropanes as CGRP antagonists, medicaments contg. said compounds and method for production thereof
12/25/2002CN1387519A 2-imino-1,3-thiazine derivs.
12/25/2002CN1387518A Heterocyclic substd, diphenyl leukotriene antagonists
12/25/2002CN1387517A 5-aryl-1H-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions contg. them
12/25/2002CN1387514A Aromatic sulfone hydroxamic acid metalloprotease inhibitor
12/25/2002CN1387508A N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
12/25/2002CN1387433A Method for administering phosphodiesterase 4 inhibitor
12/25/2002CN1387431A Combination comprising beta 2 adranoreceptor agonist and lenkotriene receptor antagonist
12/25/2002CN1387404A Method and compositions for treating pulmonary diseases
12/25/2002CN1386540A Medicine for treating mastropathy by exteriorly applying to acupoints
12/25/2002CN1386534A Powdered medicine for setting up bone, antalgic purpose and relaxing tendons
12/25/2002CN1386532A Exterior-applied antalgic medicine and its preparing process
12/25/2002CN1386520A Chinese medicine composition for treating acute mastitis, mastroplasia and hysteromyoma
12/25/2002CN1386519A Plaster for treating rheumatism
12/25/2002CN1386514A Chinese medicine for treating rheumatic arthritis
12/25/2002CN1096861C Method of treating androgenic alopecia with 5-alpha reductase inhibitors
12/25/2002CN1096860C Topical ketoconazole compositions
12/24/2002US6498274 Amide derivatives for the treatment of diseases mediated by cytokines
12/24/2002US6498243 Epimorphin antagonist and process for producing it
12/24/2002US6498178 Inhibitors of IMPDH enzyme
12/24/2002US6498177 Alpha 2 adrenergic receptor agonist; analgesic, sedative and anaesthetic agents
12/24/2002US6498173 Treatment of diseases based on acute or chronic obstruction of vessels and/or bronchi and/or inflammation
12/24/2002US6498166 Pyrazolopyridines
12/24/2002US6498165 Pyrimidine compounds; prophylaxis and treatment of such as immune diseases, hyperproliferative disorders, cancer, angiogensis, atheroscelerosis, graft rejection, rheumatoid arthritis, psoriasis
12/24/2002US6498164 Such as 1,3-dibenzyl-5-(phenyl- or 2-thienyl-acetyl)barbi-turic acid; malignant hypercalcemia, osteolytic diseases such as paget's disease, osteoporosis, articular rheumatism occurring in knees, shoulders, joints
12/24/2002US6498162 Treating inflammatory and allergic diseases of respiratory tract and diseases of central nervous system
12/24/2002US6498160 For therapy of emphysema, chronic bronchitis, asthma and allergic rhinitis
12/24/2002US6498158 Il-5 inhibiting 6-azauracil derivatives
12/24/2002US6498151 Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors
12/24/2002US6498148 Immunization-free methods for treating antigen-stimulated inflammation in a mammalian host and shifting the host's antigen immune responsiveness to a Th1 phenotype
12/24/2002CA2150812C Catechol diethers as selective pde iv inhibitors
12/24/2002CA2086264C Surface complexed lymphotoxin
12/24/2002CA2075878C Cyclic peptides and use thereof
12/23/2002WO2002094290A1 Use of lps for treating intestinal inflammation processes
12/23/2002WO2001098255A1 Process for the production of calcium pantothenate
12/23/2002CA2414288A1 Use of lps in the treatment of intestinal inflammatory processes
12/23/2002CA2413413A1 Method for preparing calcium pantothenate
12/19/2002WO2002101394A2 Screening method which uses bnpi and dnpi
12/19/2002WO2002101048A2 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
12/19/2002WO2002101046A1 Monoclonal antibody binding to mt4-mmp catalytic domain
12/19/2002WO2002101008A2 Intracellular signaling molecules
1 ... 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 ... 1272